TransMedics Group, Inc.
做多
已更新

TMDX Long

331
Think of this company like AMZN only in the organ transplant field

Demand urgency is literally life or death and its a no brainer at these prices

Their moat is not only but mainly regulatory in the USA since they are the only company that are licensed for heart, lung and kidney

They are expanding to Europe so their margins might be under pressure for the next quarters

Furthermore narrative was negative that due to higher oil prices margins are under more pressure, but since the decline in TMDX and crude this seems to be a clear divergence

Original entry was at or below 70 but anything under 74 seems good now, no brainer long term

For shorter term take profits are TP1: 86 TP2: at or above 100

That being said if next earnings disappoints a retrace to 70 or dip to 65 is not impossible
交易开始
Seems bullish here for a new push above 80$
注释
TP1 hit

免责声明

这些信息和出版物并非旨在提供,也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。